Company profile DNLI

Denali Therapeutics Inc
Description of the company is not available.
Quarter analysis & expected interestLast update: February 08 2024 20:24:55.

After 39 days of this quarter the interest is at 147.0. Based on that we can calculate that during remaining 52 days it will total up to 343.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019285
400
40.4% QoQ
386
-3.5% QoQ
271
-29.8% QoQ
2020 424
48.8% YoY 56.5% QoQ
337
-15.8% YoY -20.5% QoQ
481
24.6% YoY 42.7% QoQ
247
-8.9% YoY -48.6% QoQ
2021 349
-17.7% YoY 41.3% QoQ
351
4.2% YoY 0.6% QoQ
385
-20.0% YoY 9.7% QoQ
244
-1.2% YoY -36.6% QoQ
2022 498
42.7% YoY 104.1% QoQ
372
6.0% YoY -25.3% QoQ
443
15.1% YoY 19.1% QoQ
437
79.1% YoY -1.4% QoQ
2023 446
-10.4% YoY 2.1% QoQ
415
11.6% YoY -7.0% QoQ
403
-9.0% YoY -2.9% QoQ
427
-2.3% YoY 6.0% QoQ
2024 147
-67.0% YoY -65.6% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Denali Therapeutics search interestLast update: February 08 2024 20:24:54.
Correlation coefficient between keyword and revenue is -0.19
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 20:24:56.

The average 5 years interest of Denali Therapeutics was 29.69 per week.
The last year interest of Denali Therapeutics compared to the last 5 years has changed by 4.68%.
The interest for Denali Therapeutics is seasonal.
The last year interest is comparable to 5 years ago. It has changed only by 3.88%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Denali Therapeutics neurodegenerative diseases to provide analysis

Correlation between past revenue and Denali Therapeutics neurodegenerative diseases search interest

There is not enough data for Denali Therapeutics neurodegenerative diseases to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Denali Therapeutics neurodegenerative diseases to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Denali Therapeutics Parkinson's disease to provide analysis

Correlation between past revenue and Denali Therapeutics Parkinson's disease search interest

There is not enough data for Denali Therapeutics Parkinson's disease to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Denali Therapeutics Parkinson's disease to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Denali Therapeutics Alzheimer's disease to provide analysis

Correlation between past revenue and Denali Therapeutics Alzheimer's disease search interest

There is not enough data for Denali Therapeutics Alzheimer's disease to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Denali Therapeutics Alzheimer's disease to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Denali Therapeutics clinical trials to provide analysis

Correlation between past revenue and Denali Therapeutics clinical trials search interest

There is not enough data for Denali Therapeutics clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Denali Therapeutics clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Denali Therapeutics collaboration agreements to provide analysis

Correlation between past revenue and Denali Therapeutics collaboration agreements search interest

There is not enough data for Denali Therapeutics collaboration agreements to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Denali Therapeutics collaboration agreements to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 20:25:01.

After 39 days of this quarter the interest is at 125.0. Based on that we can calculate that during remaining 52 days it will total up to 292.0.
Denali Therapeutics stock expected interest is significantly higher compared to same quarter last year (+62.2%) but similar to previous quarter.

YearQ1Q2Q3Q4
201963
234
271.4% QoQ
227
-3.0% QoQ
122
-46.3% QoQ
2020 159
152.4% YoY 30.3% QoQ
182
-22.2% YoY 14.5% QoQ
268
18.1% YoY 47.3% QoQ
113
-7.4% YoY -57.8% QoQ
2021 221
39.0% YoY 95.6% QoQ
296
62.6% YoY 33.9% QoQ
256
-4.5% YoY -13.5% QoQ
272
140.7% YoY 6.2% QoQ
2022 170
-23.1% YoY -37.5% QoQ
194
-34.5% YoY 14.1% QoQ
227
-11.3% YoY 17.0% QoQ
131
-51.8% YoY -42.3% QoQ
2023 180
5.9% YoY 37.4% QoQ
78
-59.8% YoY -56.7% QoQ
167
-26.4% YoY 114.1% QoQ
474
261.8% YoY 183.8% QoQ
2024 125
-30.6% YoY -73.6% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Denali Therapeutics stock search interestLast update: February 08 2024 20:25:00.
Correlation coefficient between keyword and revenue is -0.48
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 20:25:02.

The average 5 years interest of Denali Therapeutics stock was 15.93 per week.
The last year interest of Denali Therapeutics stock compared to the last 5 years has changed by 17.07%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 32.65%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Denali Therapeutics jobs to provide analysis

Correlation between past revenue and Denali Therapeutics jobs search interest

There is not enough data for Denali Therapeutics jobs to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Denali Therapeutics jobs to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Denali Therapeutics reviews to provide analysis

Correlation between past revenue and Denali Therapeutics reviews search interest

There is not enough data for Denali Therapeutics reviews to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Denali Therapeutics reviews to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 20:25:06.

After 39 days of this quarter the interest is at 135.0. Based on that we can calculate that during remaining 52 days it will total up to 315.0.
Denali Therapeutics -stock -company expected interest is significantly lower compared to same quarter last year (-42.4%) but similar to previous quarter.

YearQ1Q2Q3Q4
2019318
413
29.9% QoQ
409
-1.0% QoQ
438
7.1% QoQ
2020 418
31.4% YoY -4.6% QoQ
266
-35.6% YoY -36.4% QoQ
488
19.3% YoY 83.5% QoQ
238
-45.7% YoY -51.2% QoQ
2021 175
-58.1% YoY -26.5% QoQ
339
27.4% YoY 93.7% QoQ
376
-23.0% YoY 10.9% QoQ
244
2.5% YoY -35.1% QoQ
2022 423
141.7% YoY 73.4% QoQ
396
16.8% YoY -6.4% QoQ
369
-1.9% YoY -6.8% QoQ
511
109.4% YoY 38.5% QoQ
2023 547
29.3% YoY 7.0% QoQ
454
14.6% YoY -17.0% QoQ
447
21.1% YoY -1.5% QoQ
345
-32.5% YoY -22.8% QoQ
2024 135
-75.3% YoY -60.9% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Denali Therapeutics -stock -company search interestLast update: February 08 2024 20:25:05.
Correlation coefficient between keyword and revenue is -0.1
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 20:25:07.

The average 5 years interest of Denali Therapeutics -stock -company was 29.69 per week.
The last year interest of Denali Therapeutics -stock -company compared to the last 5 years has changed by 12.83%.
The interest for Denali Therapeutics -stock -company is seasonal.
The last year interest is comparable to 5 years ago. It has changed only by -3.12%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for DNLI
Earnings date: 2024-02-26 After close
Company name: Denali Therapeutics Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-14T16:54:22Z

Analyst Upgrades
Morgan Stanley Maintains Overweight on Denali Therapeutics, Lowers Price Target to $40

2026-05-11T09:55:01Z

Analyst Upgrades
BTIG Reiterates Buy on Denali Therapeutics, Maintains $39 Price Target

2026-05-08T13:37:37Z

Analyst Upgrades
Wedbush Maintains Outperform on Denali Therapeutics, Lowers Price Target to $23

2026-05-07T20:01:00Z

GlobeNewswire
Denali Therapeutics Reports First Quarter 2026 Financial Results and Business Highlights

2026-04-20T12:30:00Z

GlobeNewswire
When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech

2026-04-07T10:48:23Z

Analyst Upgrades
Baird Maintains Outperform on Denali Therapeutics, Raises Price Target to $34

2026-04-03T17:30:00Z

GlobeNewswire
Denali Therapeutics Regains Full Rights to Investigational Therapy DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN)

2026-03-31T20:49:00-04:00

PR Newswire
The $578 Billion Regenerative Medicine Market Has a Manufacturing Problem. One Company Just Solved the First Step

2026-03-26T17:46:05Z

Analyst Upgrades
Morgan Stanley Maintains Overweight on Denali Therapeutics, Raises Price Target to $42

2026-03-26T15:37:59Z

Analyst Upgrades
Goldman Sachs Maintains Buy on Denali Therapeutics, Raises Price Target to $40

2026-03-26T14:36:35Z

Analyst Upgrades
Stifel Maintains Buy on Denali Therapeutics, Raises Price Target to $41

2026-03-26T12:30:47Z

Analyst Upgrades
FDA Clears Denali Therapeutics Drug As First Brain-Penetrating Biologic For Rare Disease

2026-03-26T11:51:54Z

Analyst Upgrades
Baird Maintains Outperform on Denali Therapeutics, Raises Price Target to $32

2026-03-26T11:37:58Z

Analyst Upgrades
HC Wainwright & Co. Maintains Buy on Denali Therapeutics, Raises Price Target to $42

2026-03-25T15:50:28Z

GlobeNewswire
Denali Therapeutics Announces U.S. FDA Approval of AVLAYAH™ (tividenofusp alfa-eknm) for Treatment of Hunter Syndrome (MPS II)